Other OpenAI introduces GPT-Rosalind, its drug discovery AI PharmaphorumIn this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.OtherRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaphorum In this week’s second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin. OtherRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Novo may have muscle advantage over Lilly in weight-loss race: preprintNext: RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
